[1]
2026. REAL-WORLD TREATMENT ADHERENCE AND OVERALL SURVIVAL IN CANCER PATIENTS RECEIVING PEMBROLIZUMAB THROUGH A PATIENT ASSISTANCE PROGRAM AT MILITARY HOSPITAL 175. Vietnam Journal of Community Medicine. 67, Số CĐ12- Bệnh viện Ung bướu Nghệ An (Aug. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD12.6167.